Associate Professor Bengt Furberg, M.D., Ph.D., new VP Medical Affairs at Artimplant

Västra Frölunda, Sweden, December 21, 2006
The biomaterials company Artimplant, engages Associate Professor Bengt Furberg, M.D., Ph.D., as Vice President Medical Affairs, effective immediately. Furberg is a physician, scientist and writer. In addition to Artimplant he has assignments in Bactiguard AB and a number of board positions.

Furberg has a wide-ranging medical background and has published some 40 articles, among others in sports medicine and clinical trials, an area in which he also writes educational literature. Moreover, Furberg has worked as a medical professional, both as head of a department of clinical physiology and as head of an occupational health centre. In addition he has long experience from the industry. For ten years Furberg was medical director of GlaxoWellcome Sweden and his latest assignment was as medical director of Bactiguard AB. He has many years experience of international requirements for obtaining regulatory clearances within pharmaceuticals and medical devices.

Hans Rosén, the CEO of Artimplant, says;

“We are pleased to have Bengt Furberg as Vice President Medical Affairs at Artimplant. Artimplant’s strategy is to develop and market medical applications based on the Company’s unique biomaterial Artelon®. Bengt Furberg will have a major influence in that process based on his medical knowledge and well-reputed experience of clinical trials and regulatory bodies. He has considerably contributed to the success of the companies where he has been operational.”